The GLP-1R agonist exenatide has been shown to have little effect on food intake in leptin deficient mice and leptin receptor null rats, whilst leptin can strongly enhance the anorectic effects of exenatide in the latter (45, 46)
After receiving the patients informed consent, we began the following treatment in July 2019: Combined therapy with oral antioxidants propolis 700 mg + bilberry 180 mg + silymarin 400 mg + ginkgo biloba 240 mg + L-carnitine 1000 mg + coenzyme Q10 100 mg + Boswellia 200 mg + vitamin E 48 mg + vitamin C 50 mg + superoxide dismutase 11,000 IU/g 10 mg/daily + topical diclofenac gel 4%/2 daily + peri-plaque penile injection (pentoxifylline 100 mg) every 2 weeks for 6 months
Among the most significant advancements in this field are GLP-1 agonists, such as Semaglutide and Tirzepatide
The interactive dosing schedule chart above shows the full week-by-week progression for both Zepbound (weight management) and Mounjaro (type 2 diabetes)
Its metabolism depends on hepatic binding proteins that selectively retain alpha-tocopherol from food for its incorporation into very low-density lipoproteins and its subsequent tissue distribution, together with esterified cholesterol and triglycerides 31